MAR 24, 2016 01:56 PM PDT

The Molecular 'Switch' that Suppresses Cancer Metastasis

WRITTEN BY: Xuan Pham

About 90% of cancer-related deaths are attributed to metastasis, events where cancer migrates from its original source other sites in the body. Why some cancers have a higher propensity to spread and how they do so is a hot topic of cancer biology.
 
A recent report helped to shed some light on this matter. Researchers identified a key protein, MARK4, which enables cancer cells to break off and colonize at distant sites. More importantly, these researchers identified the corresponding micro-RNA – a silencer molecule – that acts to repress MARK4 and thus reduces metastasis. The results offer a new target for anticancer therapy, as well as a potential biomarker for predicting the likelihood of metastasis for any given patient.
 

Image credit: Pixabay.com

In studying breast and lung cancer tissues, researchers honed in on a protein that seemed to aid cancer metastasis. The protein is a kinase made from the gene known as MAP/microtubule affinity regulating kinase 4, or MARK4, and is involved in cell cycle control. The exact mechanism of how MARK4 enables cancer cells to break off and travel to distant sites in the body is still being investigated.
 
But researchers did find that MARK4 expression is silenced by a micro-RNA known as miR-515-5p. Micro-RNAs (miRNAs) are short, non-coding RNA sequences that regulate gene expression by binding at the 3’-untranslated region of a target. In this case, miR-515-5p binds to the end of the MARK4 transcript and prevents its expression.
 
The researchers confirmed this in a cell culture model of breast and lung cancer. They observed the same results in a metastatic cancer mouse model, where increasing the amount of miR-515-5p reduced tumor spread. Consistent with their expectations, the researchers found lower amounts of this micro-RNA in tumors that had already spread throughout the body.
 
For cancer, survival rate is inversely correlated with metastasis. Thus, lower amounts of the silencer miRNA are likely correlated lower survival, as metastasis risks are higher. Indeed, researchers found lower survival rates when they examined breast and lung cancer patients who expressed low levels of miR-515-5p.
 
 “In our work we have shown that this silencer molecule is important in the spread of cancer. This is very early stage research, so we now need more studies to find out more about this molecule, and if it is present in other types of cancer," said Justin Stebbing, professor at the Imperial College London and senior study author.
 
The results provide two avenues of molecular targets for cancer therapy. Researchers could target MARK4 to block its expression or otherwise stop it from promoting cancer cell proliferation. In the same vein, researchers could target miR-515-5p, either by increasing its expression or affinity to the MARK4 transcript. In these scenarios, the goal is to dampen MARK4 expression so as to prevent cancer cell migration outside of its primary site.
 
Another implication from these results will be a potentially new diagnostic tool for the prediction of cancer metastasis. Since metastasis is correlated to the levels of MARK4 and miR-515-5p, a test that accurately measures these biomarkers could reveal to doctors the likelihood of the cancer spreading. This will guide future treatments for the patients, and hopefully increase survival outcomes.
 

 
Additional source: EurekAlert!

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 29, 2018
Immunology
AUG 29, 2018
Artificial Intelligence Predicts Response to Immunotherapy
Artificial intelligence can process CT scan images to determine biological and clinical information that can predict immunotherapy efficacy thanks to machine learning....
NOV 02, 2018
Cell & Molecular Biology
NOV 02, 2018
Natural Molecule Enables Obese Mice to Shed Weight
A molecule that has been a focus of cancer research has been found to be a significant regulator of metabolism....
NOV 12, 2018
Cancer
NOV 12, 2018
Targeted radiation therapy may provide new hope to children with difficult-to-treat liver cancer
Primary malignant liver tumors are rare in children with an occurrence rate of 1-2% of all childhood cancers. Radical surgical resection of the liver which means the removal of part of the li...
NOV 13, 2018
Immunology
NOV 13, 2018
Yin & Yang: The Duality of Cancer-Associated Fibroblasts in Pancreatic Cancer
Pancreatic Cancer is a devastating disease. Fifty-five thousand new patients were diagnosed this year in the United States (1). It is painful and usua...
NOV 26, 2018
Cell & Molecular Biology
NOV 26, 2018
New Insight Into the Machinery That Drives Cell Death
When cells are worn out and damaged or diseased, they can initiate a self-destruct sequence called apoptosis....
DEC 06, 2018
Microbiology
DEC 06, 2018
A Bacterial Protein can Encourage Cancer Development
It's been suggested that a fifth of all cancers are caused by microbial infections, and new work indicates that the estimate is probably low....
Loading Comments...